Erectile Dysfunction
📧 Sign up to get email alerts when something new happens for Erectile Dysfunction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: Clinical Observation of Ningmitai Capsule in Treating Chronic Pelvic Pain Syndrome With Erectile Dysfunction [Phase 4]
Phase 4 clinical trial observing Ningmitai Capsule for chronic pelvic pain syndrome with erectile dysfunction has completed.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Clinical Investigation Using MED3000 Gel or Tadalafil Tablets in the Treatment of Erectile Dysfunction [Phase 3]
Phase 3 clinical trial update for MED3000 Gel or tadalafil tablets in erectile dysfunction; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Radiological Evaluation of the Penis Before and After a Botox Injection [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating the radiological effects of Botox injection on the penis for erectile dysfunction; current status is u…
-
FDA approval · 2023-08-29FDA Approved: SILDENAFIL CITRATE — Original Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' sildenafil citrate tablets as an original application (ANDA216383), establishing a generic version of …
-
CLINICAL_TRIALS trial_result · 2023-08-29Clinical Trial Update: The Role of Platelet Rich Plasma for Erectile Dysfunction [Phase 3]
A Phase 3 clinical trial evaluating platelet-rich plasma for erectile dysfunction was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-07-25Clinical Trial Update: Use of Indocyanine Green in Robotic Prostate Surgeries [Phase 4]
Phase 4 trial update on using indocyanine green in robotic prostate surgeries, with conditions including prostate cancer adenocarcinoma and …
-
CLINICAL_TRIALS trial_result · 2023-07-10Clinical Trial Update: Low Intensity Shockwaves Therapy for the Treatment of Erectile Dysfunction. 12- Month Follow-Up [NA]
A terminated clinical trial investigating low intensity shockwave therapy for erectile dysfunction with 12-month follow-up results posted.
-
FDA approval · 2023-06-30FDA Approved: VARDENAFIL HYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
The FDA approved a supplemental application for vardenafil hydrochloride from Alembic Pharmaceuticals Limited, updating the approval status …
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Efficacy and Safety of TPN171H in the Patients With Erectile Dysfunction [Phase 2]
Phase 2 clinical trial results summarize efficacy and safety of TPN171H in erectile dysfunction.
-
CLINICAL_TRIALS trial_result · 2023-06-02Clinical Trial Update: Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for Brachytherapy [Phase 2]
Phase 2 trial evaluating bicalutamide and dutasteride versus standard care for prostate cytoreduction prior to brachytherapy in prostate can…
-
FDA approval · 2023-04-24FDA Approved: TADALAFIL — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for tadalafil filed by Camber Pharmaceuticals, Inc. This action grants an updated approval related t…
-
FDA approval · 2023-04-19FDA Approved: SILDENAFIL — Original Application (Macleods Pharmaceuticals Limited)
FDA approved a generic sildenafil citrate tablet from Macleods Pharmaceuticals Limited as an Original Application (ANDA).
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: Efficacy and Safety of Toronto Association in the Treatment of Erectile Dysfunction and Premature Ejaculation [Phase 3]
Phase 3 trial evaluating efficacy and safety of Toronto Association for Erectile Dysfunction and Premature Ejaculation; not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2023-04-03Clinical Trial Update: Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer [Phase 2]
Phase 2 trial evaluating pentoxifylline, atorvastatin, and vitamin E for erectile dysfunction after prostate cancer radiation therapy; study…
-
CLINICAL_TRIALS trial_result · 2023-03-07Clinical Trial Update: Efficacy and Safety Study of TPN171H Tablets in Erectile Dysfunction. [Phase 3]
Phase 3 trial evaluating the efficacy and safety of TPN171H tablets for erectile dysfunction has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-01Clinical Trial Update: Clinical Trial Studying the Efficacy and Safety of IP2018 in Depressed, Erectile Dysfunction (ED) Patients [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of IP2018 in patients with erectile dysfunction is in progress, with the status …
-
EMA approval · 2023-02-24EMA Authorised: Vizarsin (sildenafil) — Krka, d.d., Novo mesto
The EMA authorised Vizarsin (sildenafil) for erectile dysfunction under Krka, d.d., Novo mesto.
-
CLINICAL_TRIALS trial_result · 2023-02-23Clinical Trial Update: Pharmacodynamic Study of TPN171H Tablets in Patients With Mild to Moderate Erectile Dysfunction [Phase 2]
Phase 2 pharmacodynamic study of TPN171H tablets in patients with erectile dysfunction has completed.
-
FDA approval · 2023-01-27FDA Approved: TADALAFIL — Supplemental Application (Solco Healthcare US, LLC)
FDA approved a supplemental application for tadalafil filed by Solco Healthcare US, LLC.
-
FDA approval · 2022-12-23FDA Approved: CAVERJECT IMPULSE — Supplemental Application (Pharmacia & Upjohn Company LLC)
The FDA approved a supplemental application for CAVERJECT IMPULSE (alprostadil) from Pharmacia & Upjohn Company LLC.
-
FDA approval · 2022-12-23FDA Approved: CAVERJECT — Supplemental Application (Pharmacia & Upjohn Company LLC)
FDA approved a supplemental application for CAVERJECT (alprostadil) submitted by Pharmacia & Upjohn Company LLC.
-
FDA approval · 2022-12-23FDA Approved: SILDENAFIL CITRATE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for sildenafil citrate as a generic product from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS withdrawal · 2022-12-21Clinical Trial Update: Natesto Testosterone Nasal Gel for Hypogonadal Men [Phase 4]
Phase 4 trial of Natesto testosterone nasal gel for hypogonadal men has been withdrawn.
-
FDA approval · 2022-12-16FDA Approved: TADALAFIL — Supplemental Application (AvKARE)
FDA supplemental approval for tadalafil from AvKARE (ANDA210608).
-
FDA approval · 2022-10-12FDA Approved: ALYQ — Original Application (Teva Pharmaceuticals, Inc.)
The FDA approved ALYQ as Teva's generic tadalafil in an original ANDA approval. The approval covers the same indications as tadalafil, inclu…